Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
Impact of Conditioning Regimen Intensity and Total Body Irradiation on Outcomes of Allogeneic Hematopoietic Cell Transplantation for Mature T-Cell Lymphomas: A Multicenter Analysis.
Journal: Transplantation and cellular therapy
Published: July 08, 2026
Prognostic factors for early mortality following allogeneic hematopoietic cell transplantation in hematologic malignancies.
Journal: Transplantation and cellular therapy
Published: May 26, 2026
Prognostic Factors for Early Mortality Following Allogeneic Hematopoietic Cell Transplantation in Hematologic Malignancies.
Journal: Transplantation and cellular therapy
Published: May 26, 2026
Ixazomib, Cyclophosphamide, and Dexamethasone (ICd), With or Without Daratumumab in Relapsed Multiple Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 14, 2026
Adopting a Standard of Care for Systemic Sclerosis: The Mayo Clinic Experience.
Journal: Arthritis care & research
Published: February 24, 2026
Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone.
Journal: Haematologica
Published: December 21, 2025
A phase II study of daratumumab and ibrutinib for relapsed/refractory chronic lymphocytic leukemia.
Journal: Blood cancer journal
Published: December 12, 2025
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front-Line Daratumumab Lenalidomide and Dexamethasone.
Journal: American journal of hematology
Published: October 15, 2025
Comparative Efficacy of Donor Lymphocyte Infusions in Augmenting Graft-versus-Leukemia Effect after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Myeloid Malignancies.
Journal: Acta haematologica
Published: September 30, 2025
Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies.
Journal: Acta haematologica
Published: September 30, 2025
Post-transplant Cyclophosphamide Reduces Bronchiolitis Obliterans Syndrome Risk Through Chronic Graft-versus-Host Disease Prevention: A Multicenter Cohort Study.
Journal: Chest
Published: September 21, 2025
Last Updated: 09/26/2026